Devmax Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Allahabad, Uttar Pradesh, India, established in 2014.
2014 Allahabad, Uttar Pradesh, India Under Process Of Striking Off
Last Updated:
About Devmax Pharmaceutical Private Limited

Devmax Pharmaceutical Private Limited, a under process of striking off private limited company, was established on 11 November 2014 in Allahabad, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U74120UP2014PTC066965. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

It upholds a active non-compliant status. Its leadership includes Vijay Tripathi (Director), Deepak Kumar Pandey (Director). It is based at Mathura Pd Moorat Gunj, Kaushambi, Allahabad, Uttar Pradesh, 212201.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74120UP2014PTC066965

  • Registration Number

    066965

  • Incorporation Date

    11 November 2014

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Under Process Of Striking Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 2 Months
Company report

Devmax Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Devmax Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Devmax Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Vijay Tripathi Director 11 Nov 2014 Current
Deepak Kumar Pandey Director 11 Nov 2014 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Devmax Pharmaceutical.

Enhance accessibility to Devmax Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Devmax Pharmaceutical revenue growth over time
Devmax Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Devmax Pharmaceutical?

Unlock access to Devmax Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Devmax Pharmaceutical?

Unlock and access historical data on people associated with Devmax Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Devmax Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Devmax Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Devmax Pharmaceutical
Recent Activity within the Organization
  • Director Appointment

    The activity Vijay Tripathi was appointed as a Director was appointed as a Director on 11 Nov 2014 & has been associated with this company since 11 years 2 months . was completed.

  • Director Appointment

    Deepak Kumar Pandey was appointed as a Director was appointed as a Director on 11 Nov 2014 & has been associated with this company since 11 years 2 months . was recorded as a recent event.

  • Company Incorporation

    The activity Devmax Pharmaceutical Private Limited was registered on 11 Nov 2014 with Roc Kanpur & aged 11 years 2 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Devmax Pharmaceutical Private Limited?

The CIN of Devmax Pharmaceutical Private Limited is U74120UP2014PTC066965.

Where is Devmax Pharmaceutical Private Limited headquartered?

Devmax Pharmaceutical Private Limited is headquartered at Mathura Pd Moorat Gunj, Kaushambi, Allahabad, Uttar Pradesh, 212201.

When was Devmax Pharmaceutical Private Limited incorporated?

Devmax Pharmaceutical Private Limited was incorporated on 11 November 2014.

Who are the current directors of Devmax Pharmaceutical Private Limited?

The current directors of Devmax Pharmaceutical Private Limited are

What is the primary industry of Devmax Pharmaceutical Private Limited?

The primary industry of Devmax Pharmaceutical Private Limited is Pharma.

Is Devmax Pharmaceutical Private Limited a listed company?

Devmax Pharmaceutical Private Limited is unlisted.

What is the capital structure of Devmax Pharmaceutical Private Limited?

The authorized capital of Devmax Pharmaceutical Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Devmax Pharmaceutical Private Limited?

The compliance status of Devmax Pharmaceutical Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available